1,043
Views
32
CrossRef citations to date
0
Altmetric
Research Paper

Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the miR-223-HSP90B1 axis

, , , &
Pages 3288-3299 | Received 14 Jul 2019, Accepted 15 Sep 2019, Published online: 15 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jiqiang Hu, Xuan Wang, Xiaoyun Cui, Wu Kuang, Dong Li & Jing Wang. (2021) Quercetin prevents isoprenaline-induced myocardial fibrosis by promoting autophagy via regulating miR-223-3p/FOXO3. Cell Cycle 20:13, pages 1253-1269.
Read now
Dewang Fu, Li’e Zang, Zhaowei Li, Chenghui Fan, Huamao Jiang & Tongyi Men. (2021) Long non-coding RNA CRNDE regulates the growth and migration of prostate cancer cells by targeting microRNA-146a-5p. Bioengineered 12:1, pages 2469-2479.
Read now
Yan Liu, Xinyi Liu, Xiaofeng Zhang, Jinhu Deng, Jian Zhang & Hao Xing. (2020) lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway. Cancer Management and Research 12, pages 2685-2695.
Read now

Articles from other publishers (29)

Rahul Bhattacharjee, Neeraj Prabhakar, Lamha Kumar, Arkadyuti Bhattacharjee, Sulagna Kar, Sumira Malik, Dhruv Kumar, Janne Ruokolainen, Arvind Negi, Niraj Kumar Jha & Kavindra Kumar Kesari. (2023) Crosstalk between long noncoding RNA and microRNA in Cancer. Cellular Oncology 46:4, pages 885-908.
Crossref
Yaxuan Wang, Haixia Zhu, Haifei Xu, Yifan Qiu, Yonghong Zhu & Xiaolin Wang. (2023) Senescence-related gene c-Myc affects bladder cancer cell senescence by interacting with HSP90B1 to regulate cisplatin sensitivity. Aging.
Crossref
Kun Li, Tongyue Yao & Ziqiang Wang. (2023) lncRNA-mediated ceRNA network in bladder cancer. Non-coding RNA Research 8:2, pages 135-145.
Crossref
Daniel Ruben Akiola Sanya & Djamila Onésime. (2023) Roles of non-coding RNAs in the metabolism and pathogenesis of bladder cancer. Human Cell 36:4, pages 1343-1372.
Crossref
Ya-Ting Chuang, Jun-Ping Shiau, Jen-Yang Tang, Ammad Ahmad Farooqi, Fang-Rong Chang, Yi-Hong Tsai, Ching-Yu Yen & Hsueh-Wei Chang. (2023) Connection of Cancer Exosomal LncRNAs, Sponging miRNAs, and Exosomal Processing and Their Potential Modulation by Natural Products. Cancers 15:8, pages 2215.
Crossref
宇欣 桂. (2023) Research Progress of lncRNA DLX6-AS1 in Malignant Tumors. World Journal of Cancer Research 13:02, pages 44-50.
Crossref
Zhimou Cai, Bingjie Tang, Lin Chen & Wenbin Lei. (2022) Mast cell marker gene signature in head and neck squamous cell carcinoma. BMC Cancer 22:1.
Crossref
Yongfeng Mo, Manying Chen, Honyu Qin, Huaying Liu & Yu Ye. (2022) Pueraria lobata Potentially Treating Prostate Cancer on Single-Cell Level by Network Pharmacology and AutoDock: Clinical Findings and Drug Targets. Computational and Mathematical Methods in Medicine 2022, pages 1-14.
Crossref
Yaxuan Wang & Xiaolin Wang. (2022) A Pan-Cancer Analysis of Heat-Shock Protein 90 Beta1(HSP90B1) in Human Tumours. Biomolecules 12:10, pages 1377.
Crossref
Hongyu Zhang, Baixiu Wu, Ka Liang, Liuhua Ke, Xingxuan Ma, Changliu Luo & You He. (2022) Association between the LINC00673 rs11655237 C> T polymorphisms with cancer risk in the Chinese population: A meta-analysis. Medicine 101:37, pages e30353.
Crossref
Yaxuan Wang, Haixia Zhu & Xiaolin Wang. (2022) Prognosis and immune infiltration analysis of endoplasmic reticulum stress-related genes in bladder urothelial carcinoma. Frontiers in Genetics 13.
Crossref
Meng-yu Jing, Lai-di Xie, Xi Chen, Ying Zhou, Meng-meng Jin, Wei-hua He, Di-min Wang & Ai-xia Liu. (2022) Circ-CCNB1 Modulates Trophoblast Proliferation and Invasion in Spontaneous Abortion by Regulating miR-223/SIAH1 axis. Endocrinology 163:8.
Crossref
Yanyan Zhao & Pei Li. (2022) Strategies of LncRNA DLX6-AS1 on Study and Therapeutics. Frontiers in Genetics 13.
Crossref
Soudeh Ghafouri-Fard, Sajad Najafi, Bashdar Mahmud Hussen, Aryan R. Ganjo, Mohammad Taheri & Mohammad Samadian. (2022) DLX6-AS1: A Long Non-coding RNA With Oncogenic Features. Frontiers in Cell and Developmental Biology 10.
Crossref
Xu Zhao, Jizhao Wang, Rui Zhu, Jing Zhang & Yunfeng Zhang. (2021) DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis. Scientific Reports 11:1.
Crossref
Yalan Luo, Peng Ge, Mengfei Wang, Haiyang Chen, Jiayue Liu, Tianfu Wei, Yuankuan Jiang, Jialin Qu & Hailong Chen. (2021) Research progress of DLX6-AS1 in human cancers. Human Cell 34:6, pages 1642-1652.
Crossref
Xuan He, He Xiao, Rui Yang, Hang Chen & Bin Wang. (2021) lncRNA LOC339524 inhibits the proliferation of bladder cancer cells by targeting the miR‑875‑5p/COPS7A signaling axis. Experimental and Therapeutic Medicine 22:5.
Crossref
Hui-Jin Li, Xue Gong, Zheng-Kun Li, Wei Qin, Chun-Xia He, Lu Xing, Xin Zhou, Dong Zhao & Hui-Ling Cao. (2021) Role of Long Non-coding RNAs on Bladder Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Ji Huang, Qiu-Ming He, Qi Wu, Wei-Min Zhou, Chao Hao, Gong-Xian Wang & Xin-Hua Tu. (2021) Long non‑coding RNA 00858 knockdown alleviates bladder cancer via regulation of the miR‑3064‑5p/CTGF axis. Oncology Reports 46:2.
Crossref
Qiuxian Zheng, Xinyu Gu, Qin Yang, Qingfei Chu, Yiyang Dai & Zhi Chen. (2021) DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression. Clinica Chimica Acta 517, pages 1-8.
Crossref
Xiaoming Liu, Dandan Peng, Yixin Cao, Yuanzhe Zhu, Jianjun Yin, Guangxing Zhang, Xiaodong Peng & Yanqiu Meng. (2020) Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis. Cancer Gene Therapy 28:5, pages 486-501.
Crossref
Chunyu Zhang, Jiao Hu, Huihuang Li, Hongzhi Ma, Belaydi Othmane, Wenbiao Ren, Zhenglin Yi, Dongxu Qiu, Zhenyu Ou, Jinbo Chen & Xiongbing Zu. (2021) Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis. Frontiers in Oncology 11.
Crossref
Chengyu Hu, Kai Liu, Bei Wang, Wen Xu, Yexiang Lin & Chengfu Yuan. (2021) DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA. Current Pharmaceutical Design 27:9, pages 1211-1218.
Crossref
Anita Alizadeh, Asiyeh Jebelli, Behzad Baradaran, Mohammad Amini, Fatemeh Oroojalian, Mahmoud Hashemzaei, Ahad Mokhtarzadeh & Michael R Hamblin. (2021) Crosstalk between long non-coding RNA DLX6-AS1, microRNAs and signaling pathways: A pivotal molecular mechanism in human cancers. Gene 769, pages 145224.
Crossref
Mohsen Sheykhhasan, Yaghoub Ahmadyousefi, Reihaneh Seyedebrahimi, Hamid Tanzadehpanah, Hamed Manoochehri, Paola Dama, Nashmin Fayazi Hosseini, Mohammad Akbari & Mohsen Eslami Farsani. (2021) DLX6-AS1: a putative lncRNA candidate in multiple human cancers. Expert Reviews in Molecular Medicine 23.
Crossref
Tiago Aparecido Silva & Hatylas Azevedo. (2020) Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer. Journal of Proteomics 229, pages 103951.
Crossref
Zilong Wu, Zihao Xu, Boyao Yu, Jingtao Zhang & Bentong Yu. (2020) The Potential Diagnostic Value of Exosomal Long Noncoding RNAs in Solid Tumors: A Meta-Analysis and Systematic Review. BioMed Research International 2020, pages 1-15.
Crossref
Liang Huang, Fei-Yan Deng & Shu-Feng Lei. (2020) Global correlation analysis for miRNA and protein expression profiles in human peripheral blood mononuclear cells. Molecular Biology Reports 47:7, pages 5295-5304.
Crossref
Qingke Chen & Lingmin Fu. (2020) Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504. PLOS ONE 15:1, pages e0227568.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.